Skip to content

Vascular dementia

Gustavo C. Román, Thomas K. Tatemichi, Timo Erkinjuntti, Jeffrey L. Cummings, Joseph C. Masdeu, Julio Herrero García, L. A. Amaducci, Jean Marc Orgogozo, A. Brun, Albert Hofman D, D. M. Moody, M D O’Brien, Takenori Yamaguchi, Jordan Henry Grafman, Burton P. Drayer, David Alan Bennett, Marc Fisher, Jun Ogata, E. Kokmen, F Bermejo, Philip A. Wolf, Philip B. Gorelick, Katherine L. Bick, Aurora K. Pajeau, Charles S DeCarli, Antonio Culebras, Amos D. Korczyn, Julien Bogousslavsky, Anders Hartmann, Peritz Scheinberg

Neurology · 1993 · 4,961 citations

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., García, J. H., Amaducci, L. A., Orgogozo, J. M., Brun, A., D, A. H., Moody, D. M., O’Brien, M. D., Yamaguchi, T., Grafman, J. H., Drayer, B. P., Bennett, D. A., Fisher, M., Ogata, J., Kokmen, E., … Scheinberg, P. (1993). Vascular dementia. Neurology, 43(2), 250. https://doi.org/10.1212/wnl.43.2.250

In text: (Román et al., 1993)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Criteria for the diagnosis of vascular dementia (VaD) that are reliable, valid, and readily applicable in a variety of settings are urgently needed for both clinical and research purposes. To address this need, the Neuroepidemiology Branch of the National Institute of Neurological Disorders and Stroke (NINDS) convened an International Workshop with support from the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN), resulting in research criteria for the diagnosis of VaD. Compared with other current criteria, these guidelines emphasize (1) the heterogeneity of vascular dementia syndromes and pathologic subtypes including ischemic and hemorrhagic strokes, cerebral hypoxic-ischemic events, and senile leukoencephalopathic lesions; (2) the variability in clinical course, which may be static, remitting, or progressive; (3) specific clinical findings early in the course (eg, gait disorder, incontinence, or mood and personality changes) that support a vascular rather than a degenerative cause; (4) the need to establish a temporal relationship between stroke and dementia onset for a secure diagnosis; (5) the importance of brain imaging to support clinical findings; (6) the value of neuropsychological testing to document impairments in multiple cognitive domains; and (7) a protocol for neuropathologic evaluations and correlative studies of clinical, radiologic, and neuropsychological features. These criteria are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible). They await testing and validation and will be revised as more information becomes available.

  1. Clinical diagnosis of Alzheimer's disease1984
  2. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment2005
  3. Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review2013
  4. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011
  5. Parkinsonism1967

Metadata from OpenAlex (CC0). Citations are generated from the published record.